Skip to content
Gluconolactone
Renacidin (gluconolactone) is a small molecule pharmaceutical. Gluconolactone was first approved as Renacidin on 1990-10-02.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Combinations
Renacidin
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Citric acid
+
Gluconolactone
+
Magnesium carbonate
Tradename
Company
Number
Date
Products
RENACIDINUnited GuardianN-019481 RX1990-10-02
1 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
dr.plinus zero troubleunapproved drug other2021-05-25
renacidinNew Drug Application2019-12-17
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
4 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Oral candidiasisD002180EFO_0007406B37.0——1——1
Hiv infectionsD015658EFO_0000764B20——1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hidradenitis suppurativaD017497L73.2—2———2
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameGLUCONOLACTONE
INN—
Description
D-glucono-1,5-lactone is an aldono-1,5-lactone obtained from D-gluconic acid. It has a role as an animal metabolite and a mouse metabolite. It is a gluconolactone and an aldono-1,5-lactone. It is functionally related to a D-gluconic acid.
Classification
Small molecule
Drug class—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
O=C1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
Identifiers
PDB—
CAS-ID90-80-2
RxCUI25842
ChEMBL IDCHEMBL1200829
ChEBI ID16217
PubChem CID7027
DrugBankDB04564
UNII ID—
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 1,626 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
12 adverse events reported
View more details